SEC Form 10-K filed by Bio-Rad Laboratories Inc.
$BIO.B
Unavailable
Unavailable
Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.
SAN DIEGO and HERCULES, Calif., Feb. 8, 2023 /PRNewswire/ -- Element Biosciences, Inc. — the developer of an innovative DNA sequencing platform disrupting genomics — and Bio-Rad Laboratories, Inc. (NYSE:BIO), a global leader in life science research and clinical diagnostic products, today announced a partnership to demonstrate the capabilities of the Bio-Rad SEQuoia RNA Sequencing Library Preparation portfolio on the Element AVITI™ Benchtop Sequencer. The Element AVITI Sequencing Platform's novel Avidity Sequencing chemistry can be easily adapted for use with the Bio-Rad SEQuo
144 - BIO-RAD LABORATORIES, INC. (0000012208) (Subject)
10-Q - BIO-RAD LABORATORIES, INC. (0000012208) (Filer)
8-K - BIO-RAD LABORATORIES, INC. (0000012208) (Filer)
4 - BIO-RAD LABORATORIES, INC. (0000012208) (Issuer)
4 - BIO-RAD LABORATORIES, INC. (0000012208) (Issuer)
SC 13G - BIO-RAD LABORATORIES, INC. (0000012208) (Subject)
SC 13G/A - BIO-RAD LABORATORIES, INC. (0000012208) (Subject)
SC 13G/A - BIO-RAD LABORATORIES, INC. (0000012208) (Subject)